NETRAMARK HOLDINGS INC
Commented by Stefan Feulner on February 24th, 2025 | 07:15 CET
Alibaba, NetraMark, Super Micro Computer – Second AI wave is underway
With the launch of the chatbot ChatGPT by OpenAI in November 2022, generative AI reached the mainstream and quickly took the stock market by storm worldwide. Companies like Nvidia, Palantir, and Super Micro Computer saw their values multiply. After a brief consolidation, new, innovative AI-related business models are currently coming to the fore. Particularly in the pharmaceutical sector, there are promising companies with the potential for exorbitant growth.
Read
Commented by Fabian Lorenz on February 20th, 2025 | 07:30 CET
Multiplier potential with AI newcomer NetraMark! Palantir and BioNTech in one share!
"Game changer!" "Quantum leap!" "Revolution!" Experts use numerous superlatives to describe the possibilities of Artificial Intelligence (AI) in medicine. What is certain is that AI offers tremendous potential to develop new medications faster and more cost-effectively. Pharmaceutical companies can save billions, and patients can be cured more quickly. The market for AI in medicine is expected to see significant double-digit growth rates in the coming years. NetraMark Holdings aims to profit from this megatrend. The AI specialist is on the verge of a breakthrough and is starting 2025 with a software update, an important partnership, and reinforcements in top management. The share price has jumped but remains a hidden gem and is anything but expensive. There is significant upside potential!
Read